INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,987,142 | -25.7% | 379,100 | -4.2% | 0.48% | -14.4% |
| Q2 2023 | $16,142,967 | +3.9% | 395,855 | -5.1% | 0.56% | +9.3% |
| Q1 2023 | $15,541,590 | -30.2% | 417,000 | -34.7% | 0.52% | +7.1% |
| Q4 2022 | $22,266,798 | -60.2% | 638,200 | -36.1% | 0.48% | -57.6% |
| Q3 2022 | $55,910,000 | -4.0% | 999,100 | -11.2% | 1.14% | -15.0% |
| Q2 2022 | $58,240,000 | +105.5% | 1,125,194 | +188.5% | 1.34% | +126.6% |
| Q1 2022 | $28,347,000 | -15.8% | 390,075 | +55.4% | 0.59% | -20.9% |
| Q3 2021 | $33,672,000 | -45.3% | 251,000 | -33.9% | 0.75% | -55.1% |
| Q2 2021 | $61,526,000 | +273.3% | 380,000 | +25.4% | 1.66% | +210.8% |
| Q4 2020 | $16,483,000 | +87.5% | 303,000 | -27.5% | 0.54% | -5.0% |
| Q2 2020 | $8,790,000 | – | 418,178 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |